Annual Operating Profit
-$31.21 M
+$312.60 K+0.99%
31 December 2023
Summary:
Cytosorbents annual operaing income is currently -$31.21 million, with the most recent change of +$312.60 thousand (+0.99%) on 31 December 2023. During the last 3 years, it has fallen by -$20.84 million (-200.95%). CTSO annual operating profit is now -1005.15% below its all-time high of -$2.82 million, reached on 31 December 2010.CTSO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$4.40 M
-$977.40 K-28.59%
30 September 2024
Summary:
Cytosorbents quarterly operating income is currently -$4.40 million, with the most recent change of -$977.40 thousand (-28.59%) on 30 September 2024. Over the past year, it has increased by +$2.95 million (+40.19%). CTSO quarterly operating profit is now -641.87% below its all-time high of $811.30 thousand, reached on 30 June 2008.CTSO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$22.08 M
+$2.95 M+11.80%
30 September 2024
Summary:
Cytosorbents TTM operating income is currently -$22.08 million, with the most recent change of +$2.95 million (+11.80%) on 30 September 2024. Over the past year, it has increased by +$6.08 million (+21.58%). CTSO TTM operating profit is now -2621.79% below its all-time high of -$811.30 thousand, reached on 31 August 2005.CTSO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTSO Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.0% | +40.2% | +21.6% |
| 3 y3 years | -200.9% | +18.7% | -39.6% |
| 5 y5 years | -100.3% | +21.9% | -15.4% |
CTSO Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -200.9% | +1.0% | -28.6% | +54.0% | -39.6% | +36.4% |
| 5 y | 5 years | -200.9% | +1.0% | -124.3% | +54.0% | -112.9% | +36.4% |
| alltime | all time | -1005.1% | +1.0% | -641.9% | +54.0% | -2621.8% | +36.4% |
Cytosorbents Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.40 M(+28.6%) | -$22.08 M(-11.8%) |
| June 2024 | - | -$3.42 M(-30.6%) | -$25.04 M(-11.1%) |
| Mar 2024 | - | -$4.93 M(-47.3%) | -$28.18 M(-9.5%) |
| Dec 2023 | -$31.21 M(-1.0%) | -$9.34 M(+27.1%) | -$31.14 M(+10.6%) |
| Sept 2023 | - | -$7.35 M(+12.1%) | -$28.16 M(-5.6%) |
| June 2023 | - | -$6.56 M(-16.9%) | -$29.82 M(-5.7%) |
| Mar 2023 | - | -$7.89 M(+24.2%) | -$31.62 M(+0.3%) |
| Dec 2022 | -$31.52 M(+38.6%) | -$6.36 M(-29.5%) | -$31.52 M(-9.2%) |
| Sept 2022 | - | -$9.02 M(+7.9%) | -$34.73 M(+11.6%) |
| June 2022 | - | -$8.36 M(+7.3%) | -$31.12 M(+12.4%) |
| Mar 2022 | - | -$7.79 M(-18.5%) | -$27.68 M(+21.7%) |
| Dec 2021 | -$22.74 M(+119.3%) | -$9.56 M(+76.9%) | -$22.74 M(+43.8%) |
| Sept 2021 | - | -$5.41 M(+9.8%) | -$15.82 M(+27.9%) |
| June 2021 | - | -$4.92 M(+72.7%) | -$12.37 M(+15.1%) |
| Mar 2021 | - | -$2.85 M(+8.3%) | -$10.74 M(+3.6%) |
| Dec 2020 | -$10.37 M(-45.3%) | -$2.63 M(+34.4%) | -$10.37 M(-21.2%) |
| Sept 2020 | - | -$1.96 M(-40.6%) | -$13.17 M(-21.8%) |
| June 2020 | - | -$3.30 M(+33.0%) | -$16.84 M(-1.9%) |
| Mar 2020 | - | -$2.48 M(-54.4%) | -$17.17 M(-9.5%) |
| Dec 2019 | -$18.97 M(+21.7%) | -$5.43 M(-3.5%) | -$18.97 M(-0.8%) |
| Sept 2019 | - | -$5.63 M(+55.0%) | -$19.13 M(+18.0%) |
| June 2019 | - | -$3.63 M(-15.3%) | -$16.21 M(-3.3%) |
| Mar 2019 | - | -$4.29 M(-23.3%) | -$16.77 M(+7.6%) |
| Dec 2018 | -$15.58 M(+58.3%) | -$5.59 M(+106.1%) | -$15.59 M(+12.9%) |
| Sept 2018 | - | -$2.71 M(-35.3%) | -$13.80 M(+4.2%) |
| June 2018 | - | -$4.19 M(+35.0%) | -$13.24 M(+16.3%) |
| Mar 2018 | - | -$3.10 M(-18.5%) | -$11.39 M(+15.7%) |
| Dec 2017 | -$9.84 M(-14.4%) | -$3.81 M(+77.1%) | -$9.84 M(-7.2%) |
| Sept 2017 | - | -$2.15 M(-7.8%) | -$10.61 M(+0.0%) |
| June 2017 | - | -$2.33 M(+49.7%) | -$10.60 M(-3.3%) |
| Mar 2017 | - | -$1.56 M(-65.9%) | -$10.96 M(-4.6%) |
| Dec 2016 | -$11.49 M(+23.5%) | -$4.57 M(+113.2%) | -$11.49 M(+19.9%) |
| Sept 2016 | - | -$2.14 M(-20.2%) | -$9.58 M(-0.1%) |
| June 2016 | - | -$2.69 M(+28.6%) | -$9.59 M(+5.0%) |
| Mar 2016 | - | -$2.09 M(-21.5%) | -$9.13 M(-1.9%) |
| Dec 2015 | -$9.30 M | -$2.66 M(+23.8%) | -$9.30 M(-2.5%) |
| Sept 2015 | - | -$2.15 M(-3.5%) | -$9.54 M(+7.5%) |
| June 2015 | - | -$2.23 M(-1.6%) | -$8.88 M(+10.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | -$2.26 M(-22.1%) | -$8.01 M(+16.1%) |
| Dec 2014 | -$6.89 M(+46.2%) | -$2.90 M(+95.7%) | -$6.90 M(+37.9%) |
| Sept 2014 | - | -$1.48 M(+8.8%) | -$5.01 M(+13.7%) |
| June 2014 | - | -$1.36 M(+18.1%) | -$4.40 M(-1.0%) |
| Mar 2014 | - | -$1.15 M(+14.9%) | -$4.45 M(-5.7%) |
| Dec 2013 | -$4.71 M(+35.0%) | -$1.00 M(+14.2%) | -$4.71 M(+4.2%) |
| Sept 2013 | - | -$879.80 K(-37.5%) | -$4.52 M(+6.6%) |
| June 2013 | - | -$1.41 M(-1.1%) | -$4.24 M(+10.3%) |
| Mar 2013 | - | -$1.42 M(+75.0%) | -$3.85 M(+10.2%) |
| Dec 2012 | -$3.49 M(-21.3%) | -$812.90 K(+35.2%) | -$3.49 M(-4.3%) |
| Sept 2012 | - | -$601.20 K(-40.4%) | -$3.65 M(-14.6%) |
| June 2012 | - | -$1.01 M(-5.4%) | -$4.27 M(-2.4%) |
| Mar 2012 | - | -$1.07 M(+10.2%) | -$4.38 M(-1.4%) |
| Dec 2011 | -$4.44 M(+57.1%) | -$968.40 K(-21.0%) | -$4.44 M(+14.7%) |
| Sept 2011 | - | -$1.23 M(+10.0%) | -$3.87 M(+13.0%) |
| June 2011 | - | -$1.11 M(-1.3%) | -$3.42 M(+14.7%) |
| Mar 2011 | - | -$1.13 M(+181.3%) | -$2.98 M(+5.7%) |
| Dec 2010 | -$2.82 M(-6.7%) | -$401.20 K(-48.6%) | -$2.82 M(-5.6%) |
| Sept 2010 | - | -$780.70 K(+15.8%) | -$2.99 M(-2.0%) |
| June 2010 | - | -$674.40 K(-30.3%) | -$3.05 M(-5.5%) |
| Mar 2010 | - | -$967.80 K(+70.4%) | -$3.23 M(+6.7%) |
| Dec 2009 | -$3.03 M(-6.7%) | -$567.90 K(-32.4%) | -$3.03 M(-10.3%) |
| Sept 2009 | - | -$840.60 K(-1.5%) | -$3.38 M(-0.9%) |
| June 2009 | - | -$853.30 K(+11.5%) | -$3.41 M(+95.6%) |
| Mar 2009 | - | -$765.60 K(-16.4%) | -$1.74 M(+7.3%) |
| Dec 2008 | -$3.24 M(+5.8%) | -$916.00 K(+5.3%) | -$1.62 M(+23.9%) |
| Sept 2008 | - | -$870.30 K(-207.3%) | -$1.31 M(+16.4%) |
| June 2008 | - | $811.30 K(-225.5%) | -$1.12 M(-56.0%) |
| Mar 2008 | - | -$646.60 K(+7.2%) | -$2.55 M(-16.7%) |
| Dec 2007 | -$3.07 M(+3.5%) | -$603.20 K(-12.1%) | -$3.07 M(-8.9%) |
| Sept 2007 | - | -$686.20 K(+11.1%) | -$3.37 M(+0.5%) |
| June 2007 | - | -$617.90 K(-46.7%) | -$3.35 M(+1.1%) |
| Mar 2007 | - | -$1.16 M(+28.4%) | -$3.31 M(+53.1%) |
| Dec 2006 | -$2.96 M | -$903.00 K(+35.1%) | -$2.16 M(+70.6%) |
| Sept 2006 | - | -$668.50 K(+15.0%) | -$1.27 M(-10.1%) |
| June 2006 | - | -$581.40 K(+5772.7%) | -$1.41 M(+70.1%) |
| Feb 2006 | - | -$9900.00(+25.3%) | -$829.10 K(+1.2%) |
| Nov 2005 | - | -$7900.00(-99.0%) | -$819.20 K(+1.0%) |
| Aug 2005 | - | -$811.30 K | -$811.30 K |
FAQ
- What is Cytosorbents annual operaing income?
- What is the all time high annual operating profit for Cytosorbents?
- What is Cytosorbents annual operating profit year-on-year change?
- What is Cytosorbents quarterly operating income?
- What is the all time high quarterly operating profit for Cytosorbents?
- What is Cytosorbents quarterly operating profit year-on-year change?
- What is Cytosorbents TTM operating income?
- What is the all time high TTM operating profit for Cytosorbents?
- What is Cytosorbents TTM operating profit year-on-year change?
What is Cytosorbents annual operaing income?
The current annual operating profit of CTSO is -$31.21 M
What is the all time high annual operating profit for Cytosorbents?
Cytosorbents all-time high annual operaing income is -$2.82 M
What is Cytosorbents annual operating profit year-on-year change?
Over the past year, CTSO annual operaing income has changed by +$312.60 K (+0.99%)
What is Cytosorbents quarterly operating income?
The current quarterly operating profit of CTSO is -$4.40 M
What is the all time high quarterly operating profit for Cytosorbents?
Cytosorbents all-time high quarterly operating income is $811.30 K
What is Cytosorbents quarterly operating profit year-on-year change?
Over the past year, CTSO quarterly operating income has changed by +$2.95 M (+40.19%)
What is Cytosorbents TTM operating income?
The current TTM operating profit of CTSO is -$22.08 M
What is the all time high TTM operating profit for Cytosorbents?
Cytosorbents all-time high TTM operating income is -$811.30 K
What is Cytosorbents TTM operating profit year-on-year change?
Over the past year, CTSO TTM operating income has changed by +$6.08 M (+21.58%)